Stop Blaming People, Start Fixing Systems: Human Error vs. System Error in Clinical Research

Mohamad-Ali Salloum, PharmD • February 13, 2026

Share

  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
E6(R3) • QbD • Risk‑Based Oversight
~6–8 min read • 0% complete

Stop Blaming “Human Error”: How ICH GCP E6(R3) Reframes Quality in Clinical Trials. Clinical trials still see the same recurring deviations—late SAE reporting, missed visit windows, outdated ICF versions, missing data. And too often, the explanation offered is simply “human error.” But the newly finalized ICH GCP E6(R3) makes it clear: lasting quality comes from system design , not blame. E6(R3) modernizes GCP with flexible, risk‑based, technology‑enabled expectations and explicitly strengthens Quality by Design (QbD), proportionality, and management of critical‑to‑quality factors.

If “human error” keeps recurring, the real cause isn’t the person—it’s the system they’re working in.

The Two Lenses: Person vs. System

The Person Approach: Retrain and Move On

This outdated model treats deviations as individual lapses—forgetfulness, miscalculations, oversight. The typical response is retraining or reminders. The outcome? The error returns because nothing structural changed.

The System Approach: Design for Reliability

E6(R3) reinforces that quality must be designed into trials from the start, not inspected in afterward. The system approach emphasizes usability of workflows, automation and digital tools, clarity of roles, proportional controls, critical‑to‑quality focus, and better data governance. That aligns with modern patient‑safety science and high‑reliability industries.

Reason’s Swiss Cheese Model still applies: every layer—protocol, SOPs, training, systems—has holes. Incidents occur when holes align. Strengthen each layer and misalign the holes.

🧠
Mindset shift: Don’t ask “Who slipped?”—ask “What made the slip likely across people and time?”
Goal: Fewer repeat deviations through better system design, not more training memos.

What ICH GCP E6(R3) Expects

  • Quality by Design (QbD): Identify critical‑to‑quality (CTQ) factors and build controls where they matter most.
  • Proportionality and Fitness‑for‑Purpose: Right‑size controls; not all data must be error‑free if reliability is preserved.
  • Modern Data Governance: Robust oversight of computerized systems, audit trails, eConsent, and remote processes—media‑neutral by design.
  • Strengthened Sponsor Responsibilities: Demonstrate process‑level oversight and rationale for decisions across the trial lifecycle—not just at closeout.
  • Support for Innovative Designs: Decentralized, digital, and pragmatic trials are enabled when risks are proactively managed.

Tip: Document why your controls are sufficient for each CTQ—this is often what inspectors want to see.

Plain‑English Definitions

Human Error: A slip or mistake by a person. Often a symptom , not the root cause.

System Error: A condition in the environment, process, tools, or workload that increases error probability across people and time.

Fixing the system reduces repeat deviations dramatically.

A CRA’s Four‑Question Decision Aid

  • Task design: Is the task dependent on memory or manual calculation? → System.
  • Environment/workload: Were interruptions, stress, or understaffing involved? → System.
  • Information/interface: Are SOPs clear and tools user‑friendly? If not → System.
  • Controls: Are there alerts, double‑checks, dashboards, or QTLs? If missing → System.

Even if a person contributed, E6(R3) expects you to assess and strengthen system barriers.

Field Scenarios: How E6(R3) Should Change Your Response

1) Late SAE Reporting

Old explanation: Coordinator forgot to report.

E6(R3) approach:

  • Process Daily AE review checklists and backup coverage.
  • Tools EMR keyword alerts and a centralized SAE tracker with due‑date warnings.
  • Oversight Weekly PI/CRA timeliness review with QbD‑aligned CTQs and QTLs.

Result: A workflow that makes timely reporting the default.

2) Out‑of‑Window Visits

Old explanation: “Staff miscalculated.”

E6(R3) approach: Validated visit‑window calculator, automatic calendar reminders, double‑checks during scheduling, and capacity planning to reduce overload—Quality by Design in action.

3) Wrong ICF Version Used

Old explanation: “Nurse grabbed the wrong form.”

E6(R3) approach: Single digital source of truth for ICFs; watermarked versions; removal of obsolete copies; eConsent with automated version control; and a CRA‑review queue for new versions.

This enhances compliance and inspection readiness.

What Inspectors Commonly Cite Under E6(R3)

  • Repeated deviations “fixed” only with retraining
  • “Human error” listed repeatedly as the root cause
  • Weak justification for controls or missing decision rationale
  • CAPAs missing effectiveness verification or closed late

Actions You Can Take This Month

  • Map a high‑risk process (e.g., SAE → reporting) and identify memory‑based steps; add automation or checklists.
  • Define critical‑to‑quality (CTQ) factors and proportional controls aligned with E6(R3).
  • Document decision‑making—not just outcomes—consistent with R3 expectations for process rationales.
  • Strengthen eTMF/CTMS oversight to ensure end‑to‑end visibility of essential records.
  • Prepare for inspections by demonstrating real‑time oversight, rationale, data governance, and continuous risk management.
🔎
The Takeaway: “Human error” is never the end of the investigation—it’s the starting point. E6(R3) emphasizes Quality by Design, proportionality, critical‑to‑quality thinking, and robust data governance. CRAs can shift monitoring from surface‑level checks to true Quality‑by‑Design oversight, preventing repeat deviations and strengthening inspection readiness.

Quick Knowledge Check

~3 minutes
1) Under E6(R3), which approach best prevents repeat deviations?
2) Which of the following is a system fix for late SAE reporting?
3) E6(R3) expects sponsors to document…
4) Which change reduces out‑of‑window visits?
5) Using the wrong ICF version is best prevented by…
Score: — / 5
Like this article?

List of Services

    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button

    ABOUT THE AUTHOR

    Mohamad-Ali Salloum, PharmD

    Mohamad Ali Salloum LinkedIn Profile

    Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.

    Share

    Recent articles:

    By Mohamad-Ali Salloum, PharmD March 30, 2026
    References: Peng Z, Jia Q, Mao J, et al. Neurotransmitters crosstalk and regulation in the reward circuit of subjects with behavioral addiction . Front Psychiatry. 2024;15. 2 Walid R. The Impact of Addiction on the Brain’s Reward Circuitry, And How This Affects the Motivation and Decision-Making Processes . 2025. 3 Parra-Abarca J, Palacios-Pérez HB, Baldivia-Noyola P, et al. The relation between the dopaminergic system, drug addiction, and brain structures related to reward behaviors and decision-making . Rev Mex Neurocienc. 2025. 4 Penn LPS Online. Neuroscience and addiction: Unraveling the brain's reward system . 2025. 1 Cold Spring Harbor Laboratory. Hijacking the Brain’s Reward System: The Neuroscience Behind Addiction . 2025.
    By Mohamad-Ali Salloum, PharmD March 28, 2026
    References: Aggarwal D, Naik J, Lindquist DH. Biphasic Model of Addiction: Neurobehavioral Adaptations . Curr Behav Neurosci Rep. 2025;12:25. 1 Blithikioti C, Fried EI, Albanese E, Field M, Cristea IA. Reevaluating the brain disease model of addiction . Lancet Psychiatry. 2025;12(6):469–474. 2 Blithikioti C, Fried EI, Albanese E, Field M, Cristea IA. Reevaluating the BrainDisease Model of Addiction (Accepted Version). University of Sheffield; 2025. Unterrainer HF. Addiction, attachment, and the brain: a focused review of empirical findings and future directions . Front Hum Neurosci. 2025;19. 3 Vaswani M. Neurobiology of Addiction . Addiction Behavioral Conference 2025. Magnus Group. 
    By Mohamad-Ali Salloum, PharmD March 24, 2026
    This guide breaks down why your body reacts the way it does, how misinterpretation fuels anxiety, and the CBT tools designed to help you understand (and stop fearing) your own physical sensations.
    By Mohamad-Ali Salloum, PharmD March 22, 2026
    This article explains why avoidance is so powerful, how it silently shapes your emotions and behaviors, and evidence‑based strategies that help you break the cycle.
    By Mohamad-Ali Salloum, PharmD March 20, 2026
    Are you having Negative Automatic Thoughts (NATs)? We got you 💆‍♂️
    By Mohamad-Ali Salloum, PharmD March 18, 2026
    Learn how to break the vicious cycle by addressing your behaviors!
    By Mohamad-Ali Salloum, PharmD March 16, 2026
    Low Mood is NOT random!
    By Mohamad-Ali Salloum, PharmD March 15, 2026
    Learn how CBT rewires thoughts, emotions, and behaviors—and test your knowledge with a quick quiz.
    By Mohamad-Ali Salloum, PharmD March 8, 2026
    A clear, engaging walkthrough of fentanyl’s pharmacokinetics and pharmacodynamics—from administration to metabolism and excretion—designed for pharmacy and medical students, with visuals, summaries, and an interactive quiz.
    More Posts